TrialClinical drug investigation2015
Effect of Febuxostat, a Xanthine Oxidase Inhibitor, on Cardiovascular Risk in Hyperuricemic Patients with Hypertension: A Prospective, Open-label, Pilot Study.
Shigemasa Tani et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
25 papers cite it
this paperpooled ittrialcites it